LGALS3 and malignant colon neoplasm: In breast and colon cancer patients, increased serum levels of galectin-1 and galectin-3 also correlated with enhanced expression of G-CSF, and IL-6 (70), suggesting a modulatory role of galectin-3 in inflammation.